CELLINK announces partnership with AstraZeneca to provide advanced 3D-bioprinted liver organoids

CELLINK, focused on the development and commercialization of innovative bioprinting technologies and bioinks, announced today that the company will collaborate with AstraZeneca to provide advanced 3D-bioprinted liver organoids for drug discovery purposes in cardiovascular, renal and metabolic diseases.

In tissue engineering, the need for assembly of three-dimensional (3D) tissues is important. 3D-bioprinting has emerged as a useful technology to recapitulate the microenvironment of native tissue, allowing for precise printing of multiple cells into a pre-defined position.

CELLINK has an R&D lab in AstraZeneca’s BioVentureHub in Gothenburg, Sweden. The new collaboration will leverage CELLINK’s innovative and patent-pending bioink, Extra Cellular Matrix and Laminin based bioinks, which enables human cells to grow and function as they would in the human body.

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    CELLINK. (2020, May 15). CELLINK announces partnership with AstraZeneca to provide advanced 3D-bioprinted liver organoids. News-Medical. Retrieved on June 04, 2020 from https://www.news-medical.net/news/20200515/CELLINK-announces-partnership-with-AstraZeneca-to-provide-advanced-3D-bioprinted-liver-organoids.aspx.

  • MLA

    CELLINK. "CELLINK announces partnership with AstraZeneca to provide advanced 3D-bioprinted liver organoids". News-Medical. 04 June 2020. <https://www.news-medical.net/news/20200515/CELLINK-announces-partnership-with-AstraZeneca-to-provide-advanced-3D-bioprinted-liver-organoids.aspx>.

  • Chicago

    CELLINK. "CELLINK announces partnership with AstraZeneca to provide advanced 3D-bioprinted liver organoids". News-Medical. https://www.news-medical.net/news/20200515/CELLINK-announces-partnership-with-AstraZeneca-to-provide-advanced-3D-bioprinted-liver-organoids.aspx. (accessed June 04, 2020).

  • Harvard

    CELLINK. 2020. CELLINK announces partnership with AstraZeneca to provide advanced 3D-bioprinted liver organoids. News-Medical, viewed 04 June 2020, https://www.news-medical.net/news/20200515/CELLINK-announces-partnership-with-AstraZeneca-to-provide-advanced-3D-bioprinted-liver-organoids.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.